Obesity, expiratory flow limitation and asthma symptoms

Pulmonary Pharmacology and Therapeutics

Volumn 26, Issue 4, 2013, Pages 438-443

  Mahadev, Sriram ^a,b,c,d   Farah, Claude S ^a,b,c   King, Gregory G ^a,b,c,d   Salome, Cheryl M ^a,b,c  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c CRC for Asthma and Airways   (Australia)

^d ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Asthma symptom control; Dyspnea; Expiratory flow limitation; Forced oscillation technique; Obesity

Indexed keywords

FLUTICASONE PROPIONATE;

ADULT; ARTICLE; ASTHMA; BRONCHOSPASM; CLINICAL ARTICLE; DISEASE ASSOCIATION; DRUG MEGADOSE; DYSPNEA; EXPIRATORY FLOW RATE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG VOLUME; MALE; OBESITY; PRIORITY JOURNAL; RESPIRATORY SYSTEM;

ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHOCONSTRICTION; CASE-CONTROL STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; MAXIMAL EXPIRATORY FLOW RATE; MIDDLE AGED; OBESITY; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84880509958     PISSN: 10945539     EISSN: 15229629     Source Type: Journal    
DOI: 10.1016/j.pupt.2012.05.004     Document Type: Article

References (48)

1. Sahebjami H. Dyspnea in obese healthy men. Chest 1998, 114:1373-1377.
2. Shore S.A., Johnston R.A. Obesity and asthma. Pharmacol Ther 2006, 110:83-102.
3. Lessard A., Turcotte H., Cormier Y., Boulet L.-P. Obesity and asthma: a specific phenotype?. Chest 2008, 134:317-323.
4. Lavoie K.L., Bacon S.L., Labrecque M., Cartier A., Ditto B. Higher BMI is associated with worse asthma control and quality of life but not asthma severity. Respir Med 2006, 100:648-657.
5. Saint-Pierre P., Bourdin A., Chanez P., Daures J.-P., Godard P. Are overweight asthmatics more difficult to control?. Allergy 2006, 61:79-84.
6. Taylor B., Mannino D., Brown C., Crocker D., Twum-Baah N., Holguin F. Body mass index and asthma severity in the national asthma survey. Thorax 2008, 63:14-20.
7. Vortmann M., Eisner M.D. BMI and health status among adults with asthma. Obesity 2008 Jan, 16:146-152.
8. Mosen D.M., Schatz M., Magid D.J., Camargo C.A. The relationship between obesity and asthma severity and control in adults. JAllergy Clin Immunol 2008, 122:507-511.
9. Sin D.D., Jones R.L., Man S.F. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002, 162:1477-1481.
10. Todd D.C., Armstrong S., D'Silva L., Allen C.J., Hargreave F.E., Parameswaran K. Effect of obesity on airway inflammation: a cross-sectional analysis of bodymass index and sputum cell counts. Clin Exp Allergy 2007, 37:1049-1054.
11. Chinn S., Jarvis D., Burney P. Relation of bronchial responsiveness to body mass index in the ECRHS. Thorax 2002, 57:1028-1033.
12. Litonjua A.A., Sparrow D., Celedon J.C., DeMolles D., Weiss S.T. Association of body mass index with the development of methacholine airway hyperresponsiveness in men: the normative aging study. Thorax 2002, 57:581-585.
13. Schachter L.M., Salome C.M., Peat J.K., Woolcock A.J. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001, 56:4-8.
14. Skloot G., Schechter C., Desai A., Togias A. Impaired response to deep inspiration in obesity. JAppl Physiol 2011, 111:726-734.
15. Farah C.S., Kermode J., Downie S.R., Brown N.J., Hardaker K.M., Berend N., et al. Obesity is a determinant of asthma control, independent of inflammation and lung mechanics. Chest 2011, 140:659-666.
16. Sulc J., Volta C., Ploysongsang Y., Eltayara L., Olivenstein R., Milic-Emili J. Flow limitation and dyspnoea in healthy supine subjects during methacholine challenge. Eur Respir J 1999, 14:1326-1331.
17. Pellegrino R., Violante B., Nava S., Rampulla C., Brusasco V., Rodarte J.R. Expiratory airflow limitation and hyperinflation during methacholine-induced bronchoconstriction. JAppl Physiol 1993, 75:1720-1727.
18. Lougheed M.D., Lam M., Forkert L., Webb K.A., O'Donnell D.E. Breathlessness during acute bronchoconstriction in asthma. Pathophysiologic mechanisms. Am Rev Respir Dis 1993, 148:1452-1459.
19. Pankow W., Podszus T., Gutheil T., Penzel T., Peter J.-H., Von Wichert P. Expiratory flow limitation and intrinsic positive end-expiratory pressure in obesity. JAppl Physiol 1998, 85:1236-1243.
20. Ferretti A., Giampiccolo P., Cavalli A., Milic-Emili J., Tantucci C. Expiratory flow limitation and Orthopnea in massively obese subjects. Chest 2001, 119:1401-1408.
21. Ofir D., Laveneziana P., Webb K.A., O'Donnell D.E. Ventilatory and perceptual responses to cycle exercise in obese women. JAppl Physiol 2007, 102:2217-2226.
22. Koulouris N.G., Hardavella G. Physiological techniques for detecting expiratory flow limitation during tidal breathing. Eur Respir Rev 2011, 20:147-155.
23. Milic-Emili J. Expiratory flow limitation. Chest 2000, 117:219S-223S.
24. Koulouris N., Valta P., Lavoie A., Corbeil C., Chasse M., Braidy J., et al. Asimple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J 1995, 8:306-313.
25. Valta P., Corbeil C., Lavoie A., Campodonico R., Koulouris N., Chasse M., et al. Detection of expiratory flow limitation during mechanical ventilation. Am J Respir Crit Care Med 1994, 150:1311-1317.
26. Ninane V., Leduc D., Kafi S.A., Nasser M., Houa M., Sergysels R. Detection of expiratory flow limitation by Manual compression of the abdominal wall. Am J Respir Crit Care Med 2001, 163:1326-1330.
27. Mead J., Whittenberger J.L. Physical properties of human lungs measured during spontaneous respiration. JAppl Physiol 1953, 5:779-796.
28. Dellaca R.L., Duffy N., Pompilio P.P., Aliverti A., Koulouris N.G., Pedotti A., et al. Expiratory flow limitation detected by forced oscillation and negative expiratory pressure. Eur Respir J 2007, 29:363-374.
29. Dellaca R.L., Santus P., Aliverti A., Stevenson N., Centanni S., Macklem P.T., et al. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J 2004, 23:232-240.
30. Salome C.M., Munoz P.A., Berend N., Thorpe C.W., Schachter L.M., King G.G. Effect of obesity on breathlessness and airway responsiveness to methacholine in non-asthmatic subjects. Int J Obes 2008, 32:502-509.
31. Simon P.M., Schwartzstein R.M., Weiss J.W., Fencl V., Teghtsoonian M., Weinberger S.E. Distinguishable types of dyspnea in patients with shortness of breath. Am Rev Respir Dis 1990, 142:1009-1014.
32. Juniper E.F., O'Byrne P.M., Roberts J.N. Measuring asthma control in group studies: do we need airway calibre and rescue beta2-agonist use?. Respir Med 2001, 95:319-323.
33. Juniper E.F., Svensson K., Mork A.C., Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 2005, 99:553-558.
34. Robinson P.D., Turner M., Brown N.J., Salome C., Berend N., Marks G.B., et al. Procedures to improve the repeatability of forced oscillation measurements in school-aged children. Respir Physiol Neurobiol 2011, 177:199-206.
35. Hankinson J., Odencrantz J., Fedan K. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999, 159:179-187.
36. Crapo R.O., Morris A.H., Clayton P.D., Nixon C.R. Lung volumes in healthy nonsmoking adults. Bull Eur Physiopathol Respir 1982, 18:419-425.
37. Yan K., Salome C., Woolcock A.J. Rapid method for measurement of bronchial responsiveness. Thorax 1983, 38:760-765.
38. Dellaca R.L., Pompilio P.P., Walker P.P., Duffy N., Pedotti A., Calverley P.M.A. Effect of bronchodilation on expiratory flow limitation and resting lung mechanics in COPD. Eur Respir J 2009, 33:1329-1337.
39. Brown N.J., Xuan W., Salome C.M., Berend N., Hunter M.L., Musk A.W., et al. Reference equations for respiratory system resistance and reactance in adults. Respir Physiol Neurobiol 2010, 172:162-168.
40. Tantucci C., Ellaffi M., Duguet A., Zelter M., Similowski T., Derenne J., et al. Dynamic hyperinflation and flow limitation during methacholine-induced bronchoconstriction in asthma. Eur Respir J 1999, 14:295-301.
41. Torchio R., Gobbi A., Gulotta C., Dellaca R.L., Tinivella M., Hyatt R.E., et al. Mechanical effects of obesity on airway responsiveness in otherwise healthy humans. JAppl Physiol 2009, 107:408-416.
42. Raviv S., Dixon A.E., Kalhan R., Shade D., Smith L.J. Effect of obesity on asthma phenotype is dependent upon asthma severity. JAsthma 2011, 48:98-104.
43. Roisman G.L., Peiffer C., Lacronique J.G., Le Cae A., Dusser D.J. Perception of bronchial obstruction in asthmatic patients. Relationship with bronchial eosinophilic inflammation and epithelial damage and effect of corticosteroid treatment. JClin Invest 1995, 96:12-21.
44. Salome C., Reddel H., Ware S., Roberts A., Jenkins C., Marks G., et al. Effect of Budesonide on the perception of induced airway narrowing in subjects with asthma. Am J Respir Crit Care Med 2002, 165:15-21.
45. Burdon J.G., Pain M.C., Rubinfeld A.R., Nana A. Chronic lung diseases and the perception of breathlessness: a clinical perspective. Eur Respir J 1994, 7:1342-1349.
46. Deesomchok A., Fisher T., Webb K.A., Ora J., Lam Y.-M., Lougheed M.D., et al. Effects of obesity on perceptual and mechanical responses to bronchoconstriction in asthma. Am J Respir Crit Care Med 2010, 181:125-133.
47. Sutherland T.J.T., Cowan J.O., Taylor D.R. Dynamic hyperinflation with bronchoconstriction: differences between obese and nonobese women with asthma. Am J Respir Crit Care Med 2008, 177:970-975.
48. Boudreau D., Styhler A., Gray-Donald K., Martin J.G. Acomparison of breathlessness during spontaneous asthma and histamine-induced bronchoconstriction. Clin Invest Med 1995, 18:25-32.